Skip to content
Riskpilot
← Back to search
Sign in
Get full access
RYL pharma AB
AB
Active
Org 5594818907
Brunnshögsgatan 48, 224 82
Lund
Retail sale of pharmaceutical products
· NACE 4773
Est. 2024
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
RYL pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
5M
0M
2024
4M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
54
3 963
Staff expenses
—
−93
EBITDA
12
461
Depreciation & amort.
—
−50
EBIT
12
411
Net financials
−8
−49
Profit before tax
4
302
Tax
−1
−63
Net profit
3
239
Balance sheet
SEK thousands
Item
2024
2025
Total assets
1 570
2 854
Equity
28
267
Long-term debt
950
1 707
Short-term debt
592
820
Total debt
1 542
2 527
Financial ratios
5-year trend
EBITDA margin
11.6%
This company
15.8%
Market median
-27% vs market
2024
2025
Equity ratio
9.4%
This company
38.2%
Market median
-75% vs market
2024
2025
Return on equity
89.5%
This company
18.4%
Market median
+386% vs market
2024
2025
Net profit margin
6.0%
This company
8.1%
Market median
-26% vs market
2024
2025
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
2024
2025
Debt / equity
9.68×
This company
0.62×
Market median
-1461% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-04-30 – 2024-12-31
View
PDF
More on RYL pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
